Climb Bio Inc (CLYM) Stock Analysis

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $7.38
• Market Cap: $483.43M
• EPS: $-0.59
• 52-Week High: $7.09
• 52-Week Low: $1.05

About Climb Bio Inc

Climb Bio, Inc. is a biotechnology company based in Wilmington, Delaware, specializing in the development of innovative therapies for autoimmune-driven inflammatory diseases. With a strong and diverse pipeline of drug candidates, Climb Bio harnesses advanced scientific research to address significant unmet medical needs in this therapeutic area. The company’s strategic focus on research and development, combined with its commitment to enhancing patient outcomes, establishes Climb Bio as a vit...

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for Climb Bio Inc and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

Does CLYM pay dividends?

Climb Bio Inc (CLYM) does not currently pay a regular dividend.

What is CLYM's market cap?

Climb Bio Inc (CLYM) has a market capitalization of $483.43M with a current stock price of $7.38.